Revolution Medicines financial statements

레볼루션 메디신NASDAQ:RVMD · Nasdaq · Healthcare · sector #16
$199.87-3.76%
2026-10-06 close · prelim

Revolution Medicines's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$690M.

Reported results

Revolution Medicines notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q